0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Reproductive & Development Sign in to save

Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review

BMC Infectious Diseases 2022 5 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 30 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Saera Park, Hyejin So, Mi‐Na Kim, Jina Lee

Summary

Researchers reviewed medical records of children with bloodstream infections from antibiotic-resistant bacteria and found that starting with non-carbapenem antibiotics — a broader, less powerful class — did not increase mortality risk as long as treatment was quickly adjusted once lab results confirmed the specific bacteria involved.

The empirical use of non-carbapenems might not be a risk factor for mortality and early microbiological outcomes in pediatric patients with ESBL-producing E. coli and K. pneumoniae BSI if early transition to appropriate antimicrobial therapy was possible.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children : a retrospective medical record review

Researchers retrospectively analyzed clinical outcomes for 53 pediatric patients with ESBL-producing E. coli and K. pneumoniae bacteremia treated with carbapenem or non-carbapenem empirical antibiotics between 2014 and 2019. They found a 30-day all-cause mortality rate of 17%, with 84.6% of non-carbapenem-treated patients switched to carbapenem therapy by day 2, suggesting non-carbapenem empirical therapy was frequently inadequate for this population.

Article Tier 2

Understanding the clinical and molecular epidemiological characteristics of carbapenem-resistant Acinetobacter baumannii infections within intensive care units of three teaching hospitals

Researchers analyzed carbapenem-resistant Acinetobacter baumannii (CRAB) — a dangerous antibiotic-resistant bacterium — in intensive care units across three hospitals and found it is common and growing increasingly resistant over time. Early identification and aggressive management are critical to stopping its spread in hospital settings.

Article Tier 2

Multidrug-resistant Escherichia coli causing diarrhea in yak calves on the Qinghai-Tibet Plateau: phenotypic characterization, whole-genome sequencing, and pathogenicity analysis

Scientists found dangerous, drug-resistant E. coli bacteria in sick yak calves in Tibet that doesn't respond to most common antibiotics. These "superbug" strains could potentially spread to humans through the food chain or environment, making infections much harder to treat. This highlights the growing global threat of antibiotic-resistant bacteria, especially in areas where antibiotics are used heavily in livestock.

Article Tier 2

Hidden threats in the plastisphere: Carbapenemase-producing Enterobacterales colonizing microplastics in river water

Researchers placed microplastics in a river near a wastewater treatment plant and found that antibiotic-resistant bacteria, including dangerous carbapenem-resistant strains, colonized the plastic surfaces. These bacteria carried multiple drug-resistance genes and virulence traits, making them potential threats to human health. The study demonstrates that microplastics in waterways can serve as floating platforms that help spread antibiotic-resistant superbugs from wastewater into the broader environment.

Meta Analysis Tier 1

Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis

This meta-analysis of 22 studies found that metagenomic next-generation sequencing (mNGS) had a substantially higher pathogen detection rate than conventional microbiological tests in hematology patients, with pooled sensitivity of 87%. The mNGS results led to antibiotic adjustments in about 50% of cases, demonstrating its clinical value for diagnosing infections in immunocompromised patients.

Share this paper